| Nancy Mcgrievy, MD | |
|
605 N Cleveland Massillon Rd, Akron, OH 44333-2241 | |
| (330) 668-6545 | |
| (330) 668-2726 |
| Full Name | Nancy Mcgrievy |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 18 Years |
| Location | 605 N Cleveland Massillon Rd, Akron, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104017037 | NPI | - | NPPES |
| 1861567091 | Other | OH | OBSTETRICAL AND GYNECOLOGICAL ASSOCIATES OF AKRON, INC. GROUP NPI |
| 2551671 | Other | OH | PARTNERS PHYSICIAN GROUP MEDICAID # |
| 9338635 | Other | OH | PARTNERS PHYSICIAN GROUP MEDICARE # |
| 3090006 | Medicaid | OH | |
| 1841239274 | Other | OH | PARTNERS PHYSICIAN GROUP TYPE 2 NPI # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35.094263 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summa Health System | Akron, OH | Hospital |
| Akron General Medical Center | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Obstetrical And Gynecological Associates Of Akron Inc | 5496789232 | 7 |
News Archive
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, and Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that they have entered into a Biopharmaceutical Development and Manufacturing Agreement.
A ground-breaking new class of oral drugs for treating breast cancer, known as cyclin-dependent kinase (CDK) inhibitors, are generally well-tolerated, with a manageable toxicity profile for most patients.
Fero Industries, Inc. is pleased to announce that it has closed the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.
Impax Laboratories, Inc. today announced that it will collaborate with Perrigo Company with respect to the development and commercialization of two extended topical drug products. The products and terms of the agreement were not disclosed.
› Verified 4 days ago
| Entity Name | Partners Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841239274 PECOS PAC ID: 4183529340 Enrollment ID: O20031202000183 |
News Archive
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, and Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that they have entered into a Biopharmaceutical Development and Manufacturing Agreement.
A ground-breaking new class of oral drugs for treating breast cancer, known as cyclin-dependent kinase (CDK) inhibitors, are generally well-tolerated, with a manageable toxicity profile for most patients.
Fero Industries, Inc. is pleased to announce that it has closed the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.
Impax Laboratories, Inc. today announced that it will collaborate with Perrigo Company with respect to the development and commercialization of two extended topical drug products. The products and terms of the agreement were not disclosed.
› Verified 4 days ago
| Entity Name | Obstetrical & Gynecological Associates Of Akron Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861567091 PECOS PAC ID: 5496789232 Enrollment ID: O20050921000936 |
News Archive
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, and Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that they have entered into a Biopharmaceutical Development and Manufacturing Agreement.
A ground-breaking new class of oral drugs for treating breast cancer, known as cyclin-dependent kinase (CDK) inhibitors, are generally well-tolerated, with a manageable toxicity profile for most patients.
Fero Industries, Inc. is pleased to announce that it has closed the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.
Impax Laboratories, Inc. today announced that it will collaborate with Perrigo Company with respect to the development and commercialization of two extended topical drug products. The products and terms of the agreement were not disclosed.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nancy Mcgrievy, MD 605 N Cleveland Massillon Rd, Akron, OH 44333-2241 Ph: (330) 668-6545 | Nancy Mcgrievy, MD 605 N Cleveland Massillon Rd, Akron, OH 44333-2241 Ph: (330) 668-6545 |
News Archive
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, and Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that they have entered into a Biopharmaceutical Development and Manufacturing Agreement.
A ground-breaking new class of oral drugs for treating breast cancer, known as cyclin-dependent kinase (CDK) inhibitors, are generally well-tolerated, with a manageable toxicity profile for most patients.
Fero Industries, Inc. is pleased to announce that it has closed the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.
Impax Laboratories, Inc. today announced that it will collaborate with Perrigo Company with respect to the development and commercialization of two extended topical drug products. The products and terms of the agreement were not disclosed.
› Verified 4 days ago
Dr. Amy M Burkett, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Park West Blvd, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-869-0052 | |
David M Nash, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 95 Arch St, Ste 250, Akron, OH 44304 Phone: 330-375-7722 Fax: 330-253-6708 | |
Cecilia A. Ellis, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 605 N Cleveland Massillon Rd, Akron, OH 44333 Phone: 330-668-6545 Fax: 330-668-2726 | |
James Graham, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 919 E Turkeyfoot Lake Rd Ste A, Akron, OH 44312 Phone: 330-899-9626 Fax: 330-633-6068 | |
John A. Black, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1622 E Turkeyfoot Lake Rd, #301, Akron, OH 44312 Phone: 330-344-8565 Fax: 330-896-7085 | |
Dr. Muriel Tabet, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Park West Blvd, Ste 200, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-865-6011 | |
L Ann Nunnally, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 839 E Market St, Akron, OH 44305 Phone: 330-535-9191 |